NAGE - NASDAQ

NB

Niagen Bioscience Inc

NAGE·NASDAQ

$3.50

-1.1%
HealthcareBiotechnology

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$278.76M
EPS0.2200
P/E Ratio15.91
Earnings Date08/05/2026

nage

Additional Paid-In Capital

Last Annual Value

240.99M

3-Year CAGR

4%

5-Year CAGR

9%

10-Year CAGR

18%

NB

Niagen Bioscience Inc Competitors Analysis of Additional Paid-In Capital

NAGE · NASDAQ
CompanyAdditional Paid-In Capital
CAGR 3Y
CAGR 5Y
CAGR 10Y
NAGE logo
Niagen Bioscience Inc
NASDAQ:NAGE
240.99M
3.3%3.7%15.9% 
PRTA logo
Prothena Corporation plc
NASDAQ:PRTA
1.63B
1.8%6.6%9.5%
AKBA logo
Akebia Therapeutics, Inc.
NASDAQ:AKBA
1.72B
2.8%2.2%16.7%
VTYX logo
Ventyx Biosciences, Inc.
NASDAQ:VTYX
808.19M
6.8%15.3%N/A
KROS logo
Keros Therapeutics, Inc.
NASDAQ:KROS
1.17B
17.9%26.1%N/A
RGNX logo
REGENXBIO Inc.
NASDAQ:RGNX
1.23B
6.4%5.8%16.1%
OLMA logo
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
0.00
N/AN/AN/A
CRVS logo
Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
474.39M
8.2%5.6%9.0%
KALV logo
KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
767.06M
14.8%12.5%126.9%
RIGL logo
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
1.41B
0.8%0.9%2.4%
ZVRA logo
Zevra Therapeutics, Inc.
NASDAQ:ZVRA
588.46M
7.6%8.2%19.1%
NB

Niagen Bioscience Inc Fair Value Envelope

NAGE · NASDAQ

Our analysis suggests that NAGE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.5, this represents a potential HIDDEN relative to our calculated worth for Niagen Bioscience Inc.

HIDDEN
Intrinsic Value
Current Price: $3.5

Related Guides

Blog Categories

Continue your NAGE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.